NCT05841563 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05841563
Title	Clinical Trial of PM54 in Advanced Solid Tumors Patients.
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	PharmaMar
Indications	pancreatic endocrine carcinoma lung non-small cell carcinoma gastric adenocarcinoma castration-resistant prostate carcinoma cervix carcinoma endometrial adenocarcinoma liposarcoma esophagus adenocarcinoma malignant pleural mesothelioma clear cell renal cell carcinoma peritoneal carcinoma breast ductal carcinoma breast lobular carcinoma small cell carcinoma ovary epithelial cancer Ewing sarcoma leiomyosarcoma transitional cell carcinoma pancreatic adenocarcinoma fallopian tube carcinoma gastric neuroendocrine neoplasm adrenocortical carcinoma synovial sarcoma prostate adenocarcinoma lung small cell carcinoma Advanced Solid Tumor skin melanoma
Therapies	PM54
Age Groups:	adult \| senior
Covered Countries	USA \| ESP \| BEL

Facility	Status	City	State	Zip	Country	Details
South Texas Accelerated Research Therapeutics	RECRUITING	San Antonio	Texas	78229-3307	United States	Details
Institut Jules Bordet	RECRUITING	Anderlecht		1070	Belgium	Details
HM Universitario Sanchinarro	RECRUITING	Madrid	M	28050	Spain	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05841563Clinical Trial Detail